Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by PurpleVine IPXiaoyan Zhou of Purplevine IP explains how the introduction of administrative measures for registering, and filing records relating to, medical devices in China should affect companies’ IP strategy -
Sponsored by RNA, Technology and IP AttorneysRachna Bakhru of RNA Technology and IP Attorneys discusses how companies are focused on green marketing and how brands are winning consumer trust
-
Sponsored by AJ ParkKate Giddens of AJ Park explains the key differences between the Australian and New Zealand tests for genericism, and provides some takeaways for brand owners
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains how the Korean boy band BTS helped reshape unfair competition law and the protection of publicity rights in South Korea
-
Sponsored by Hechanova GroupNew rules affecting deadlines for actions in inter partes cases in the Philippines come into effect on June 30 2022, as Editha R Hechanova of Hechanova & Co explains
-
Sponsored by Tilleke & GibbinsSher Hann Chua of Tilleke & Gibbins Thailand discusses the latest revision to Thailand’s guidelines on franchising, focusing on the changes to the first-refusal requirement
